Home › Kanser sa Prostate › Florida › Orlando
Pag-aaral pangklinika para sa Kanser sa Prostate sa Orlando, FL
Isang pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orlando. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Advent Health, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi ang layo
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Nagre-recruitPhase 2/3
- AdventHealth, Orlando
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Nagre-recruitPhase 3
- AdventHealth, Orlando
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Nagre-recruitPhase 2
- Orlando VA Medical Center, Orlando, FL, Orlando
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Nagre-recruitPhase 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Nagre-recruit
- AdventHealth, Orlando
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
Nagre-recruitPhase 1/2
- Research Site, Orlando
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Nagre-recruitPhase 1
- Sarah Cannon Research Institute @ Florida Cancer, Orlando
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- Research Site, Orlando
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
Nagre-recruitPhase 1
- AdventHealth Orlando, Orlando
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- Florida Cancer Specialists & Research Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · 17 mi ang layo
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Adventhealth, Orlando
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #8, Orlando
Exploring the Potential of Robotic Telesurgery in Remote Settings
Nagre-recruit
- AdventHealth, Celebration · 17 mi ang layo
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
Nagre-recruitPhase 2
- AdventHealth, Orlando
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN43 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Orlando
- Non-Small Cell Lung Cancer44 pag-aaral
- Obesity32 pag-aaral
- Metastatic Cancer29 pag-aaral
- Overweight27 pag-aaral
- Sakit ni Alzheimer25 pag-aaral
- Type 2 Diabetes25 pag-aaral
- Kanser (lahat ng uri)24 pag-aaral
- Kanser sa Suso23 pag-aaral
- Kanser sa Ovary22 pag-aaral
- Ulcerative Colitis22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Colorectal Cancer19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.